Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of Random Start Ovarian Stimulation with Corifollitropin Alpha and Desogestrel in Oocyte Donors
NCT03895099Phase 3Completed
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Sep 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of desogestrel in infertility (5 arms), sponsored by Centre Hospitalier Intercommunal de Créteil. Primary endpoint: Number of oocytes punctured at 45 days. Started Sep 2020; status: completed.
02
Drugs
desogestrel
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03895099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03895099.